News How VIB drives drug discovery with cryo-EM toolbox 07/01/2021 VIB today introduces an upgrade to its toolbox for structural analysis of biological molecules, leading the way for drug development. These tools help to overcome critical obstacles that limit the resolution of cryo-electron microscopy (cryo-EM) reconstructions. 19 VIB researchers among the most highly cited researchers 23/11/2020 Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists. VIB scientists Jean-Christophe Marine, Jan Steyaert, and Alain Goossens elected as EMBO Members 07/07/2020 EMBO is an organization that unites leading researchers in the life sciences to promotes scientific excellence. Every year, new members are selected from among Europe’s top-scientists. This year, Jean-Christophe Marine (VIB-KU Leuven), Jan Steyaert (VIB-VUB), and Alain Goossens (VIB-UGent) join the other VIB EMBO members. Crossing borders to empower top tech 02/04/2019 How the Nanobody expertise of Jan Steyaert's lab contributes to new discoveries. 2018 was a year full of highlights for Jan Steyaert (VIB-VUB Center for Structural Biology) and his research team, with two papers published in Cell and four in Nature. The trend continues in 2019, with two Nature publications, one Cell paper and a key technology licensing agreement already in the books. Research center for high-resolution electron cryogenic microscopy to open 21/09/2018 The Center for Structural Biology (VIB-VUB), headed by Professors Jan Steyaert and Han Remaut officially opened the ‘international facility for Bio Electron Cryogenic Microscopy’ (BECM) at the VUB Campus in Brussels. The research center houses the a new kind cryo-electron microscope (cryo-EM), one of just three in the world. The microscope pushes the boundaries of research into active proteins for the development of medicines and, thanks to its unique properties, will be operating on a 24/7 basis. Wim Versées receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 20/05/2017 Wim Versées, staff scientists at the VIB-VUB Center for Structural Biology, received a Michael J. Fox Foundation grant. The foundation provides funding for translational and clinical research supporting Parkinson’s-related breakthroughs. How tech transfer transforms new technologies into life-impacting solutions 13/12/2016 People in and around VIB are well aware of our adage: basic research as a starting point for tangible solutions that benefit society. But translating a paper or a technology into a groundbreaking new drug or agricultural application doesn’t happen overnight. The importance of the tech transfer process was recently illustrated by a study led by Nico Callewaert (VIB-UGent) and Jan Steyaert (VIB-VUB). The paper presents a technology platform for synthetic biology, and is a great example of how innovation and entrepreneurship go hand in hand. Scientists track down possible new treatment for epilepsy 26/09/2016 Increasing the concentration of specific fats in the brain could suppress epileptic seizures. This is evident from ground-breaking research carried out by the research groups of Professor Patrik Verstreken (VIB-KU Leuven) and Professor Wim Versées (VIB-Vrije Universiteit Brussel). The results of their close collaboration have been published in the leading trade journal Nature Structural & Molecular Biology.
How VIB drives drug discovery with cryo-EM toolbox 07/01/2021 VIB today introduces an upgrade to its toolbox for structural analysis of biological molecules, leading the way for drug development. These tools help to overcome critical obstacles that limit the resolution of cryo-electron microscopy (cryo-EM) reconstructions.
19 VIB researchers among the most highly cited researchers 23/11/2020 Each year, Clarivate publishes a ‘highly cited researchers’ list recognizing pioneers in their field. This list contains researchers who have demonstrated significant influence through the publication of multiple papers, highly cited by their peers, during the last decade (2009-2019). No less than 19 VIB researchers are part of this highly acclaimed group of influential scientists.
VIB scientists Jean-Christophe Marine, Jan Steyaert, and Alain Goossens elected as EMBO Members 07/07/2020 EMBO is an organization that unites leading researchers in the life sciences to promotes scientific excellence. Every year, new members are selected from among Europe’s top-scientists. This year, Jean-Christophe Marine (VIB-KU Leuven), Jan Steyaert (VIB-VUB), and Alain Goossens (VIB-UGent) join the other VIB EMBO members.
Crossing borders to empower top tech 02/04/2019 How the Nanobody expertise of Jan Steyaert's lab contributes to new discoveries. 2018 was a year full of highlights for Jan Steyaert (VIB-VUB Center for Structural Biology) and his research team, with two papers published in Cell and four in Nature. The trend continues in 2019, with two Nature publications, one Cell paper and a key technology licensing agreement already in the books.
Research center for high-resolution electron cryogenic microscopy to open 21/09/2018 The Center for Structural Biology (VIB-VUB), headed by Professors Jan Steyaert and Han Remaut officially opened the ‘international facility for Bio Electron Cryogenic Microscopy’ (BECM) at the VUB Campus in Brussels. The research center houses the a new kind cryo-electron microscope (cryo-EM), one of just three in the world. The microscope pushes the boundaries of research into active proteins for the development of medicines and, thanks to its unique properties, will be operating on a 24/7 basis.
Wim Versées receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 20/05/2017 Wim Versées, staff scientists at the VIB-VUB Center for Structural Biology, received a Michael J. Fox Foundation grant. The foundation provides funding for translational and clinical research supporting Parkinson’s-related breakthroughs.
How tech transfer transforms new technologies into life-impacting solutions 13/12/2016 People in and around VIB are well aware of our adage: basic research as a starting point for tangible solutions that benefit society. But translating a paper or a technology into a groundbreaking new drug or agricultural application doesn’t happen overnight. The importance of the tech transfer process was recently illustrated by a study led by Nico Callewaert (VIB-UGent) and Jan Steyaert (VIB-VUB). The paper presents a technology platform for synthetic biology, and is a great example of how innovation and entrepreneurship go hand in hand.
Scientists track down possible new treatment for epilepsy 26/09/2016 Increasing the concentration of specific fats in the brain could suppress epileptic seizures. This is evident from ground-breaking research carried out by the research groups of Professor Patrik Verstreken (VIB-KU Leuven) and Professor Wim Versées (VIB-Vrije Universiteit Brussel). The results of their close collaboration have been published in the leading trade journal Nature Structural & Molecular Biology.
